The Paediatric Clinical Trials Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
High Costs Related to Clinical Studies Likely to Hamper Industry Growth
As per studies, paediatric clinical trials cost 2 to 5 times higher per patient compared to clinical trials conducted in adults. Hidden costs and patient recruitment are major factors impacting the paediatric clinical trial landscape. In addition, informed consent process involving children further adds unique and complex challenges along with costs. Consent of only one parent/guardian is adequate for a child’s participation in studies such as blood tests, urinalysis, slight dietary alterations, and few psychological tests. However, depending on the severity and complexity of the trial the child’s consent may be required along with parental consent. Paediatric consent then results in additional costs due to additional documentation, need for amendments, study delays due to recruitment and retention, and longer visits to the study centres. These factors lead to high-cost burden in conducting paediatric clinical trials that may impact the growth of the market.
What Questions Should You Ask before Buying a Market Research Report?
• How is the paediatric clinical trials market evolving?
• What is driving and restraining the paediatric clinical trials market?
• How will each Paediatric clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Paediatric clinical trials submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Paediatric clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Paediatric clinical trials projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Paediatric clinical trials projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the paediatric clinical trials market?
• Where is the paediatric clinical trials market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Paediatric Clinical Trials Market today, and over the next 10 years:
• Our 230-page report provides 118 tables, 165 charts, and graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Paediatric Clinical Trials Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Paediatric clinical trials prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Indication
• Infectious Disease
• Oncology
• Autoimmune/Inflammatory Diseases
• Respiratory Disorders
• Mental Health Disorders
• Other Indications
Phase
• Phase 1
• Phase 2
• Phase 3
• Phase 4
Study Design
• Interventional Studies
• Observational Studies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Paediatric clinical trials Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• BMS
• Charles River Laboratories
• GSK
• ICON plc
• IQVIA Inc.
• LabCorp Drug Development
• Novartis
• Pfizer Inc.
• PPD Inc.
• Premier Research
• QPS Holdings
• Syneos Health
• The Emmes Company, LLC
Overall world revenue for Paediatric clinical trials Market, 2023 to 2033 in terms of value the market will surpass US$21,253.7 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Paediatric clinical trials Market, 2023 to 2033 report help you?
In summary, our 230-page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Paediatric clinical trials Market, 2023 to 2033 Market, with forecasts for indication, phase, and study design, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Paediatric clinical trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the Paediatric clinical trials Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Paediatric clinical trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Paediatric Clinical Trials Market Report 2023-2033: Forecasts by Indication (Infectious Disease, Oncology, Autoimmune/Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other), by Phase (Phase 1, Phase 2, Phase 3, Phase 4), by Study Design (Interventional Studies, Observational Studies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Paediatric Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increased Focus on Developing Economies
3.2.1.2 High Prevalence of Diseases Among Children
3.2.2 Market Restraining Factors
3.2.2.1 High Costs Related to Clinical Studies are Restraining Growth of the Market
3.2.3 Market Opportunities
3.2.3.1 Rise in Investments for Paediatric Research
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
4 Paediatric Clinical Trials Market Analysis by Indication
4.1 Key Findings
4.2 Indication Segment: Market Attractiveness Index
4.3 Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
4.4 Infectious Diseases
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Oncology
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Autoimmune/Inflammatory Diseases
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Respiratory Disorders
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Mental Health Disorders
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Other Indications
4.9.1 Market Size by Region, 2023-2033 (US$ Mn)
4.9.2 Other Disease Market Share by Region, 2023 & 2033 (%)
5 Paediatric Clinical Trials Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
5.4 Paediatric Clinical Trials Market Share by Phase, 2023 & 2033
5.5 Phase 1
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Phase 2
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Phase 3
5.7.1 Market Size by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Phase 4
5.8.1 Market Size by Region, 2023-2033 (US$ Mn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Paediatric Clinical Trials Market Analysis by Study design
6.1 Key Findings
6.2 Study design Segment: Market Attractiveness Index
6.3 Paediatric Clinical Trials Market Share by Study design, 2023 & 2033
6.4 Interventional Studies
6.4.1 Market Size Estimation, 2023-2033 (US$ Mn)
6.5 Observational studies
6.5.1 Market Size Estimation, 2023-2033 (US$ Mn)
7 Paediatric Clinical Trials Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Paediatric Clinical Trials Market Analysis
8.1 Key Findings
8.2 North America Paediatric Clinical Trials Market Attractiveness Index
8.3 North America Paediatric Clinical Trials Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
Source: Visiongain, 2023
8.4 North America Paediatric Clinical Trials Market Size Estimation and Forecast by Country
8.5 North America Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
8.6 North America Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
8.7 U.S. Paediatric Clinical Trials Market Analysis
8.7.1 U.S. Paediatric Clinical Trials Market by Indication
8.8 Canada Paediatric Clinical Trials Market Analysis
8.8.1 Canada Paediatric Clinical Trials Market by Indication
9 Europe Paediatric Clinical Trials Market Analysis
9.1 Key Findings
9.2 Europe Paediatric Clinical Trials Market Attractiveness Index
9.3 Europe Paediatric Clinical Trials Market Size by Country, 2023-2033 (US$ Mn)
9.4 Europe Paediatric Clinical Trials Market Size Estimation and Forecast by Country
9.5 Europe Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
9.6 Europe Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
9.7 Germany Paediatric Clinical Trials Market Analysis
9.7.1 Germany Paediatric Clinical Trials Market by Indication
9.8 U.K. Paediatric Clinical Trials Market Analysis
9.8.1 U.K. Paediatric Clinical Trials Market by Indication
9.9 France Paediatric Clinical Trials Market Analysis
9.9.1 France Paediatric Clinical Trials Market by Indication
9.10 Italy Paediatric Clinical Trials Market Analysis
9.10.1 Italy Paediatric Clinical Trials Market by Indication
9.11 Spain Paediatric Clinical Trials Market Analysis
9.11.1 Spain Paediatric Clinical Trials Market by Indication
9.12 Rest of Europe Paediatric Clinical Trials Market Analysis
9.12.1 Rest of Europe Paediatric Clinical Trials Market by Indication
10 Asia Pacific Paediatric Clinical Trials Market Analysis
10.1 Key Findings
10.2 Asia Pacific Paediatric Clinical Trials Market Attractiveness Index
10.3 Asia Pacific Paediatric Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Asia Pacific Paediatric Clinical Trials Market Size Estimation and Forecast by Country
10.5 Asia Pacific Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
10.6 Asia Pacific Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
10.7 Japan Paediatric Clinical Trials Market Analysis
10.7.1 Japan Paediatric Clinical Trials Market by Indication
10.8 China Paediatric Clinical Trials Market Analysis
10.8.1 China Paediatric Clinical Trials Market by Indication
10.9 India Paediatric Clinical Trials Market Analysis
10.9.1 India Paediatric Clinical Trials Market by Indication
10.10 South Korea Paediatric Clinical Trials Market Analysis
10.10.1 South Korea Paediatric Clinical Trials Market by Indication
10.11 Australia Paediatric Clinical Trials Market Analysis
10.11.1 Australia Paediatric Clinical Trials Market by Indication
10.12 Rest of Asia Pacific Paediatric Clinical Trials Market Analysis
10.12.1 Rest of Asia Pacific Paediatric Clinical Trials Market by Indication
11 Latin America Paediatric Clinical Trials Market Analysis
11.1 Key Findings
11.2 Latin America Paediatric Clinical Trials Market Attractiveness Index
11.3 Latin America Paediatric Clinical Trials Market Size Estimation and Forecast by Country
11.4 Latin America Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
11.5 Latin America Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
11.6 Brazil Paediatric Clinical Trials Market Analysis
11.6.1 Brazil Paediatric Clinical Trials Market by Indication
11.7 Mexico Paediatric Clinical Trials Market Analysis
11.7.1 Mexico Paediatric Clinical Trials Market by Indication
11.8 Rest of Latin America Paediatric Clinical Trials Market Analysis
11.8.1 Rest of Latin America Paediatric Clinical Trials Market by Indication
12 MEA Paediatric Clinical Trials Market Analysis
12.1 Key Findings
12.2 MEA Paediatric Clinical Trials Market Attractiveness Index
12.3 MEA Paediatric Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 MEA Paediatric Clinical Trials Market Size Estimation and Forecast by Country
12.5 MEA Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
12.6 South Africa Paediatric Clinical Trials Market Analysis
12.6.1 South Africa Paediatric Clinical Trials Market by Indication
12.7 GCC Paediatric Clinical Trials Market Analysis
12.7.1 GCC Paediatric Clinical Trials Market by Indication
12.8 Rest of MEA Paediatric Clinical Trials Market Analysis
12.8.1 Rest of MEA Paediatric Clinical Trials Market by Indication
13 Company Profiles
13.1 Pfizer
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2019-2022
13.1.3.2 Regional Market Shares, 2022
13.1.3.3 R&D, 2019-2022
13.1.4 Product Benchmarking
13.1.5 Strategic Outlook
13.2 GSK
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2019-2022
13.2.3.2 Regional Market Shares, 2022
13.2.3.3 R&D, 2019-2022
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 BMS
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2019-2022
13.3.3.2 Regional Market Shares, 2022
13.3.3.3 R&D, 2019-2022
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Novartis
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2019-2022
13.4.3.2 Regional Market Shares, 2022
13.4.3.3 R&D, 2019-2022
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Charles River
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2019-2022
13.5.3.2 Regional Market Shares, 2022
13.6 LabCorp Drug Development
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2019-2022
13.6.3.2 Regional Market Shares, 2022
13.6.4 Product Benchmarking
13.7 ICON plc
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2019-2022
13.7.3.2 Regional Market Shares, 2022
13.8 IQVIA Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2019-2022
13.8.3.2 Regional Market Shares, 2022
13.8.4 Product Benchmarking
13.9 PPD Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2019-2022
13.9.3.2 Regional Market Shares, 2022
13.9.3.3 R&D, 2019-2022
13.9.4 Product Benchmarking
13.10 Syneos Health
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2019-2022
13.10.3.2 Regional Market Shares, 2022
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 Premier Research
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 QPS Holdings
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Strategic Outlook
13.13 The Emmes Company, LLC
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Paediatric Clinical Trials Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 7 Pipeline of Paediatric Clinical Trials
Table 8 Infectious Disease Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 9 Pipeline of Paediatric Clinical Trials
Table 10 Oncology Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 11 Pipeline of Paediatric Clinical Trials
Table 12 Autoimmune/Inflammatory Diseases Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 13 Pipeline of Paediatric Clinical Trials
Table 14 Respiratory Disorders Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 15 Pipeline of Paediatric Clinical Trials
Table 16 Mental Health Disorders Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 17 Pipeline of Paediatric Clinical Trials
Table 18 Other Indications Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 19 Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 20 Pipeline: Paediatric Clinical Trials in Phase 1
Table 21 Phase 1 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 22 Pipeline: Paediatric Clinical Trials in Phase 2
Table 23 Phase 2 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 24 Pipeline: Paediatric Clinical Trials in Phase 3
Table 25 Phase 3 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 26 Pipeline: Paediatric Clinical Trials in Phase 4
Table 27 Phase 4 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 28 Interventional Studies Segment Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 29 Observational Studies Segment Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 30 Paediatric Clinical Trials Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 31 North America Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 32 North America Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 33 North America Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 34 US Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 35 US Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 36 Canada Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 37 Canada Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 38 Europe Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 39 Paediatric Clinical Trials Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 40 Europe Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 41 Europe Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 42 Germany Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 43 Germany Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 44 UK Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 45 UK Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 46 France Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 47 France Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 48 Italy Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 49 Italy Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 50 Spain Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 51 Spain Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 52 Rest of Europe Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 53 Rest of Europe Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 54 Asia Pacific Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 55 Asia Pacific Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 56 Asia Pacific Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 57 Asia-Pacific Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 58 Japan Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 59 Japan Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 60 China Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 61 China Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 62 India Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 63 India Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 64 South Korea Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 65 South Korea Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 66 Australia Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 67 Australia Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 68 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 69 Rest of Asia Pacific Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 70 Latin America Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 71 Latin America Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 72 Latin America Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 73 Brazil Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 74 Brazil Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 75 Mexico Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 76 Mexico Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 77 Rest of Latin America Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 78 Rest of LATAM Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 79 MEA Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 80 MEA Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 81 South Africa Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 82 South Africa Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 83 GCC Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 84 GCC Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 85 Rest of MEA Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 86 Rest of MEA Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 87 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Pfizer: Product Benchmarking
Table 89 Pfizer Inc: Company Recent Developments
Table 90 GSK: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 GSK: Product Benchmarking
Table 92 GSK: Company Recent Developments
Table 93 BMS: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 BMS: Product Benchmarking
Table 95 BMS: Company Recent Developments
Table 96 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Novartis: Product Benchmarking
Table 98 Novartis: Company Recent Developments
Table 99 Charles River: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 LabCorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 LabCorp Drug Development: Product Benchmarking
Table 102 ICON: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 IQVIA Inc.: Product Benchmarking
Table 105 PPD Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 PPD Inc.: Product Benchmarking
Table 107 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Syneos Health: Product Benchmarking
Table 109 Syneos Health: Company Recent Developments
Table 110 Premier Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Premier Research: Product Benchmarking
Table 112 Premier Research: Company Recent Developments
Table 113 QPS Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 QPS Holdings: Company Recent Developments
Table 115 Emmes: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Emmes: Product Benchmarking
List of Figures
Figure 1 Paediatric Clinical Trials Market Segmentation
Figure 2 Paediatric Clinical Trials Market by Indication: Market Attractiveness Index
Figure 3 Paediatric Clinical Trials Market by Phase: Market Attractiveness Index
Figure 4 Paediatric Clinical Trials Market: Market Dynamics
Figure 5 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 6 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 7 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 8 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 9 Paediatric Clinical Trials Market: Porter’s Five Forces Analysis
Figure 10 Paediatric Clinical Trials Market by Indication: Market Attractiveness Index
Figure 11 Paediatric Clinical Trials Market Share Forecast by Indication, 2023 and 2033 (%)
Figure 12 Paediatric Clinical Trials Market Forecast by Indication, 2023 & 2033 (%)
Figure 13 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Infectious diseases Market Share by Region, 2023 & 2033 (%)
Figure 15 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 16 Oncology Market Share by Region, 2023 & 2033 (%)
Figure 17 Autoimmune/Inflammatory Diseases Market Forecast by Region, 2023-2033 (US$ Million)
Figure 18 Autoimmune/Inflammatory Diseases Market Share Forecast by Region, 2023-2033 (%)
Figure 19 Respiratory Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 20 Respiratory Disorders Market Share Forecast by Region, 2023-2033 (%)
Figure 21 Mental Health Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 22 Mental Health Disorders Market Share by Region, 2023 & 2033 (%)
Figure 23 Other Disease Market Forecast by Region, 2023-2033 (US$ Million)
Figure 24 Other Disease Market Share by Region, 2023 & 2033 (%)
Figure 25 Paediatric Clinical Trials Market by Phase: Market Attractiveness Index
Figure 26 Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 27 Paediatric Clinical Trials Market Share Forecast by Phase, 2023, 2033 (%)
Figure 28 Phase 1 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Phase 1 Market Share by Region, 2023 & 2033 (%)
Figure 30 Phase 2 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Phase 2 Market Share by Region, 2023 & 2033 (%)
Figure 32 Phase 3 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Phase 3 Market Share by Region, 2023 & 2033 (%)
Figure 34 Phase 4 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 Phase 4 Market Share by Region, 2023 & 2033 (%)
Figure 36 Paediatric Clinical Trials Market by Study design: Market Attractive Index
Figure 37 Paediatric Clinical Trials Market Share Forecast by Study design, 2023, 2033 (%)
Figure 38 Paediatric Clinical Trials Market Forecast by Interventional studies, 2023-2033 (US$ Million, AGR %)
Figure 39 Paediatric Clinical Trials Market Forecast by Observational studies, 2023-2033 (US$ Million, AGR %)
Figure 40 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 41 Paediatric Clinical Trials Market Share Forecast by Region 2023 and 2033(%)
Figure 42 Paediatric Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue)
Figure 43 North America Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 44 North America Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ million, AGR%)
Figure 45 North America Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 47 North America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 48 North America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 49 North America Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 50 North America Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 51 U.S. Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 52 U.S. Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 53 U.S. Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 54 Canada Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 55 Canada Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 56 Canada Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 57 Europe Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 58 Europe Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million)
Figure 59 Europe Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 60 Europe Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 61 Europe Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 62 Europe Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 63 Europe Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 64 Europe Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 65 Germany Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 Germany Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 67 Germany Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 68 UK Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 U.K. Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 70 U.K. Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 71 France Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 France Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 73 France Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 74 Italy Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Italy Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 76 Italy Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 77 Spain Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 78 Spain Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 79 Spain Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 80 Rest of Europe Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 81 Rest of Europe Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 82 Rest of Europe Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 83 Asia Pacific Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 84 Asia Pacific Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 85 Asia Pacific Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 86 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Asia Pacific Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 88 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 89 Asia Pacific Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 90 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 91 Japan Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Japan Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 93 Japan Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 94 China Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 95 China Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 96 China Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 97 India Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 India Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 99 India Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 100 South Korea Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 South Korea Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 102 South Korea Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 103 Australia Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Australia Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 105 Australia Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 106 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Asia Pacific Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 109 Latin America Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 110 Latin America Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 111 Latin America Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 112 Latin America Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Latin America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 115 Latin America Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 116 Latin America Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 117 Brazil Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 Brazil Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 119 Brazil Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 120 Mexico Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Mexico Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 122 Mexico Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 123 Rest of Latin America Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 Rest of Latin America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 125 Rest of Latin America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 126 MEA Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 127 MEA Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 128 MEA Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 129 MEA Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 130 MEA Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 131 MEA Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 132 South Africa Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 133 South Africa Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 134 South Africa Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 135 GCC Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 136 GCC Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 137 GCC Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 138 Rest of MEA Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 Rest of MEA Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 140 Rest of MEA Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 141 Pfizer: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 142 Pfizer: Regional Market Shares, 2022
Figure 143 Pfizer: R&D, 2019-2022 (US$ million, AGR%)
Figure 144 GSK: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 145 GSK: Regional Market Shares, 2022
Figure 146 GSK: R&D, 2019-2022 (US$ million, AGR%)
Figure 147 BMS: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 148 BMS: Regional Market Shares, 2022
Figure 149 BMS: R&D, 2019-2022 (US$ million, AGR%)
Figure 150 Novartis: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 151 Novartis: Regional Market Shares, 2022
Figure 152 Novartis: R&D, 2019-2022 (US$ million, AGR%)
Figure 153 Charles River: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 154 Charles River: Regional Market Shares, 2022
Figure 155 LabCorp Drug Development: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 156 LabCorp Drug Development: Regional Market Shares, 2022
Figure 157 ICON plc: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 158 ICON plc: Regional Market Shares, 2022
Figure 159 IQVIA Inc.: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 160 IQVIA Inc.: Regional Market Shares, 2022
Figure 161 PPD Inc.: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 162 PPD Inc.: Regional Market Shares, 2022
Figure 163 PPD Inc.: R&D, 2019-2022 (US$ million, AGR%)
Figure 164 Syneos Health: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 165 Syneos Health: Regional Market Shares, 2022
List of Companies Profiled in the Report
BMS
Charles River Laboratories
GSK
ICON plc
IQVIA Inc.
LabCorp Drug Development
Novartis
Pfizer Inc.
PPD Inc.
Premier Research
QPS Holdings
Syneos Health
The Emmes Company, LLC
List of Other Companies Mentioned in the Report
Advanced Clinical
Clintec
CTI
Fisher Clinical Services
KCR
Medpace
Parexel
Pharm-Olam
PRA Health Sciences
Worldwide Clinical Trials
Wuxi AppTec
List of Associations Mentioned in the Report
American Academy of Paediatrics
American College of Paediatricians
Children's Hospital Association
European Union Drug Regulating Authorities Clinical Trials Database
Food and Drug Administration
International Paediatric Association
World Health Organization
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
